Probi AB (publ) (PROB.ST)
SEK 347.0
(-0.29%)
SEK 347.0
(-0.29%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 220.21 Million SEK | -13.79% |
| 2022 | 255.44 Million SEK | -11.31% |
| 2021 | 288 Million SEK | -7.08% |
| 2020 | 309.95 Million SEK | 6.28% |
| 2019 | 291.64 Million SEK | 4.9% |
| 2018 | 278.03 Million SEK | 0.04% |
| 2017 | 277.92 Million SEK | 2.62% |
| 2016 | 270.82 Million SEK | 77.17% |
| 2015 | 152.86 Million SEK | 59.11% |
| 2014 | 96.07 Million SEK | 23.55% |
| 2013 | 77.76 Million SEK | -5.07% |
| 2012 | 81.91 Million SEK | 5.63% |
| 2011 | 77.54 Million SEK | 9.96% |
| 2010 | 70.52 Million SEK | 16.81% |
| 2009 | 60.37 Million SEK | 10.16% |
| 2008 | 54.8 Million SEK | 30.5% |
| 2007 | 41.99 Million SEK | 17.11% |
| 2006 | 35.85 Million SEK | -33.17% |
| 2005 | 53.65 Million SEK | -14.37% |
| 2004 | 62.65 Million SEK | 14.62% |
| 2003 | 54.66 Million SEK | 8.31% |
| 2002 | 50.47 Million SEK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 49.05 Million SEK | -20.05% |
| 2024 Q1 | 49.39 Million SEK | 1.65% |
| 2024 Q2 | 61.35 Million SEK | 24.22% |
| 2023 Q3 | 51.22 Million SEK | 9.65% |
| 2023 Q2 | 46.72 Million SEK | -36.0% |
| 2023 Q4 | 48.59 Million SEK | -5.15% |
| 2023 Q1 | 73 Million SEK | 37.77% |
| 2023 FY | 220.21 Million SEK | -13.79% |
| 2022 Q3 | 58.85 Million SEK | -24.26% |
| 2022 Q2 | 77.7 Million SEK | 17.91% |
| 2022 FY | 255.44 Million SEK | -11.31% |
| 2022 Q4 | 52.98 Million SEK | -9.96% |
| 2022 Q1 | 65.9 Million SEK | -20.21% |
| 2021 Q4 | 82.59 Million SEK | 24.13% |
| 2021 Q1 | 74.32 Million SEK | -5.28% |
| 2021 Q2 | 64.54 Million SEK | -13.17% |
| 2021 Q3 | 66.54 Million SEK | 3.1% |
| 2021 FY | 288 Million SEK | -7.08% |
| 2020 Q3 | 88.93 Million SEK | 9.83% |
| 2020 Q2 | 80.97 Million SEK | 31.49% |
| 2020 FY | 309.95 Million SEK | 6.28% |
| 2020 Q1 | 61.58 Million SEK | -21.92% |
| 2020 Q4 | 78.47 Million SEK | -11.76% |
| 2019 Q2 | 89.78 Million SEK | 54.62% |
| 2019 Q1 | 58.07 Million SEK | -23.33% |
| 2019 Q3 | 64.91 Million SEK | -27.7% |
| 2019 Q4 | 78.87 Million SEK | 21.5% |
| 2019 FY | 291.64 Million SEK | 4.9% |
| 2018 Q3 | 80.12 Million SEK | 11.22% |
| 2018 Q1 | 50.11 Million SEK | 2.29% |
| 2018 FY | 278.03 Million SEK | 0.04% |
| 2018 Q4 | 75.74 Million SEK | -5.47% |
| 2018 Q2 | 72.04 Million SEK | 43.75% |
| 2017 Q3 | 56.41 Million SEK | -26.93% |
| 2017 Q2 | 77.21 Million SEK | -20.29% |
| 2017 Q1 | 96.86 Million SEK | 7.96% |
| 2017 Q4 | 48.99 Million SEK | -13.16% |
| 2017 FY | 277.92 Million SEK | 2.62% |
| 2016 Q3 | 64.32 Million SEK | 20.79% |
| 2016 Q1 | 63.51 Million SEK | 177.48% |
| 2016 FY | 270.82 Million SEK | 77.17% |
| 2016 Q4 | 89.72 Million SEK | 39.49% |
| 2016 Q2 | 53.25 Million SEK | -16.16% |
| 2015 Q3 | 38.46 Million SEK | -8.72% |
| 2015 Q2 | 42.14 Million SEK | -14.64% |
| 2015 Q4 | 22.89 Million SEK | -40.49% |
| 2015 FY | 152.86 Million SEK | 59.11% |
| 2015 Q1 | 49.36 Million SEK | 78.37% |
| 2014 Q4 | 27.67 Million SEK | 9.73% |
| 2014 FY | 96.07 Million SEK | 23.55% |
| 2014 Q3 | 25.22 Million SEK | 12.48% |
| 2014 Q2 | 22.42 Million SEK | 8.03% |
| 2014 Q1 | 20.75 Million SEK | 12.08% |
| 2013 Q2 | 20.44 Million SEK | 2.91% |
| 2013 Q1 | 19.86 Million SEK | 0.09% |
| 2013 FY | 77.76 Million SEK | -5.07% |
| 2013 Q4 | 18.51 Million SEK | -2.19% |
| 2013 Q3 | 18.93 Million SEK | -7.39% |
| 2012 Q3 | 17.18 Million SEK | -12.22% |
| 2012 FY | 81.91 Million SEK | 5.63% |
| 2012 Q1 | 25.02 Million SEK | 41.55% |
| 2012 Q2 | 19.57 Million SEK | -21.78% |
| 2012 Q4 | 19.84 Million SEK | 15.5% |
| 2011 Q2 | 20.07 Million SEK | -9.39% |
| 2011 Q3 | 17.75 Million SEK | -11.58% |
| 2011 Q4 | 17.67 Million SEK | -0.42% |
| 2011 FY | 77.54 Million SEK | 9.96% |
| 2011 Q1 | 22.15 Million SEK | 32.75% |
| 2010 Q1 | 15.93 Million SEK | 0.0% |
| 2010 FY | 70.52 Million SEK | 16.81% |
| 2010 Q3 | 24.54 Million SEK | 69.32% |
| 2010 Q4 | 16.69 Million SEK | -32.01% |
| 2010 Q2 | 14.49 Million SEK | -9.03% |
| 2009 FY | 60.37 Million SEK | 10.16% |
| 2008 FY | 54.8 Million SEK | 30.5% |
| 2007 FY | 41.99 Million SEK | 17.11% |
| 2006 FY | 35.85 Million SEK | -33.17% |
| 2005 FY | 53.65 Million SEK | -14.37% |
| 2004 FY | 62.65 Million SEK | 14.62% |
| 2003 FY | 54.66 Million SEK | 8.31% |
| 2002 FY | 50.47 Million SEK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AcuCort AB | 6.59 Million SEK | -3240.61% |
| AlzeCure Pharma AB (publ) | -476 Thousand SEK | 46363.235% |
| BioGaia AB (publ) | 950.19 Million SEK | 76.824% |
| Enzymatica AB (publ) | 31.86 Million SEK | -591.125% |
| Enorama Pharma AB (publ) | -3.9 Million SEK | 5745.04% |
| Gabather AB (publ) | - SEK | -Infinity% |
| Klaria Pharma Holding AB (publ.) | -9000.00 SEK | 2446911.111% |
| Moberg Pharma AB (publ) | -2.09 Million SEK | 10591.329% |
| Nanexa AB (publ) | 59.15 Million SEK | -272.252% |
| Newbury Pharmaceuticals AB (publ) | 16.03 Million SEK | -1273.498% |
| ODI Pharma AB | -1.34 Million SEK | 16513.779% |
| Orexo AB (publ) | 549.9 Million SEK | 59.954% |
| Swedencare AB (publ) | 164.8 Million SEK | -33.624% |
| Swedish Orphan Biovitrum AB (publ) | 14.05 Billion SEK | 98.433% |
| Toleranzia AB | -919 Thousand SEK | 24062.242% |
| Vivesto AB | -10.65 Million SEK | 2166.563% |